Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antibacterial wound infection therapies - Atterx Biotherapeutics

Drug Profile

Research programme: antibacterial wound infection therapies - Atterx Biotherapeutics

Alternative Names: Acinetobacter baumannii combat infections therapy - Atterx Biotherapeutics; Atterx Biotherapeutics 2041; Atterx Biotherapeutics 2043; Atterx Biotherapeutics B-040405; Atterx Biotherapeutics B-070604; Atterx Biotherapeutics B-120900; B-4474; Conjucin Agents; Conjucins; Wound infections therapies - Atterx Biotherapeutics

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ConjuGon
  • Developer Atterx Biotherapeutics
  • Class
  • Mechanism of Action Gene transference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Wound infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Wound-infections in USA
  • 17 Aug 2005 Preclinical trials in Urinary tract infections in USA (unspecified route)
  • 17 Aug 2005 Preclinical trials in Wound infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top